Laboratory Corporation of America Holdings (NYSE:LH) reported earnings of $2.47 per share beating Walls Streets expectations.

0

Laboratory Corporation of America Holdings (NYSE:LH) reported Q2 2017 earnings this Morning, coming in at $2.47 per share, beating Wall Street’s estimates of $2.40 per Share. Revenue for the quarter came in at $2.50 billion beating analyst estimates of $2.47 billion

Analyst Coverage For Laboratory Corporation of America Holdings (NYSE:LH)
These are 5 Hold Ratings, 7 Buy Ratings .
The current consensus rating for Laboratory Corporation of America Holdings (NYSE:LH) is Buy (Score: 2.58) with a consensus target price of $156.64 , a potential (0.19% downside)

Recent Insider Trading for Laboratory Corporation of America Holdings (NYSE:LH)

  • On 5/22/2017 Lance Berberian, SVP, sold 3,613 with an average share price of $139.84 per share and the total transaction amounting to $505,241.92.
  • On 5/9/2017 Jean-Luc Belingard, Director, sold 992 with an average share price of $142.19 per share and the total transaction amounting to $141,052.48.
  • On 3/9/2017 Glenn A Eisenberg, CFO, sold 2,300 with an average share price of $142.47 per share and the total transaction amounting to $327,681.00.
  • On 2/24/2017 Robert E Mittelstaedt Jr, Director, sold 5,300 with an average share price of $142.69 per share and the total transaction amounting to $756,257.00.
  • On 8/9/2016 Lisa J Uthgenannt, Insider, sold 1,177 with an average share price of $140.00 per share and the total transaction amounting to $164,780.00.
  • On 8/4/2016 Glenn A Eisenberg, CFO, sold 8,000 with an average share price of $140.10 per share and the total transaction amounting to $1,120,800.00.



    Recent Trading for Laboratory Corporation of America Holdings (NYSE:LH)
    Shares of Laboratory Corporation of America Holdings closed the previous trading session at 161.96 up +5.03 3.21% with 1,033,708 shares trading hands.